financetom
Business
financetom
/
Business
/
Protagonist Therapeutics Insider Sold Shares Worth $707,750, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Protagonist Therapeutics Insider Sold Shares Worth $707,750, According to a Recent SEC Filing
Apr 3, 2024 4:48 AM

07:27 AM EDT, 04/03/2024 (MT Newswires) -- Dinesh V Patel Ph D, Director, President and CEO, on April 01, 2024, sold 25,000 shares in Protagonist Therapeutics ( PTGX ) for $707,750. Following the Form 4 filing with the SEC, Patel has control over a total of 549,590 shares of the company, with 549,590 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1377121/000110465924042744/xslF345X03/tm2410626-1_4seq1.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved